Therapeutic Cataract & Refractive

Flavio Mantelli, MD, PhD, Chief Medical Officer at Dompé, shares about the company's role in nerve growth factor (NGF) applications in ophthalmic disease and other human indications.

A look back on what's happened in optometry during the week of Jan. 28-Feb. 2.

A look back on what's happened in optometry during the week of Jan. 21-Jan. 26.

Researchers found that prompt intervention may improve the prognosis of fungal endophthalmitis caused by contaminated medical products.

Benefits include eliminating eyeglass problems and boosting patient confidence.

A look back on what's happened in optometry during the week of Jan. 14-Jan. 19.

Novel drops for a variety of indications are under investigation.

As demand for this lens grows, the need for expert refractive comanagement will expand as well.

An increase in screen time has led to a rise in binocular vision disorders.

The glaucoma field is on the move with significant innovations in a number of treatment areas. Experts discussed the various technologies at the Optometry Times 2022 EyeCon meeting in Marco Island, Florida.

According to the authors, a patient with bilateral choroid metastases from breast cancer experienced "a dramatic response" after a combination treatment of abemaciclib and fulvestrant.

As technology advances and choices grow, you need to personalize patients’ options.

Modern technology enables early detection, individualized solutions.

Intact corneal tissue can be reused for preservation and reimplantation.

Presbyopia-correcting drops for patients with low, up-close visual function.

Evolution of vision correction procedures, diagnostics paves way for collaborative care.

Optometrists must identify and mitigate complications for this patient base.

Eyecare practitioners' top misconceptions just may surprise you.

Water gradient tech, high-tech materials, and new therapies offer more options.

Johnson & Johnson Vision receives FDA-approval of lens parameter expansion for their ACUVUE Abiliti Overnight Therapeutic Lenses for Myopia Management.

Evolving phakic IOL offers high-definition vision.

As technology improves, less-invasive treatments save patients time and money.

Justin Schweitzer, OD, FAAO, reports that glaucoma therapy is quickly moving to more innovative and targeted ways to treat glaucoma and lower the patient treatment burden.

Postoperative scenario tracks potential complications.

Results from a parallel arm study suggest opportunity to expand on visual performance and productivity improvement.